← All candidates
Twelve insider buys in the last year — $174.93M in all.
69 filings on record.
MPLTMapLight Therapeutics, Inc.
NasdaqGS · Healthcare · $546.79M
$11.40
-5.63% today
Twelve insider buys in the last year — $174.93M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 12 buys● 16 sells◆ 8 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$546.79M
Float
17.0M
39% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
10% owner
Catalyst4, Inc.
Bought $92.50M on Oct 28 — 5,441,176 sh @ $17.00, held indirect, 28% of their stake.
1 of 1 position beat the S&P
10% owner
Novo Holdings A/S
Bought $16.20M on Oct 28 — 952,941 sh @ $17.00, held direct, 26% of their stake.
First Form 4 on file
Director
Garnett Timothy John
Bought $252.7K on Feb 10 — 14,124 sh @ $17.89, held indirect, 100% of their stake.
0 of 1 position beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
4 filingsnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
64 more transactions on Pro →Context
Wall St
$26.69 avg target
+134.1% vs today · 13 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
0 of 4 quarters beat
Q2 '26−$1.32 act−$0.01
Q1 '26−$1.34 act−$0.25
Q4 '25−$2.47 act−$1.64
Q3 '25−$37.18 act−$35.45
Coverage
Is MapLight Therapeutics, Inc. (MPLT) Stock a Biotech Opportunity Ahead of the ZEPHYR Trial Readout?Insider Monkey · 06-30MapLight's CFO Just Sold 36,000 Shares for $1 Million. Is It a Buy, Sell, or Hold?Motley Fool · 05-15This MapLight Insider Sold 69,000 Shares for $2.1 Million at the End of AprilMotley Fool · 05-04We're Hopeful That MapLight Therapeutics (NASDAQ:MPLT) Will Use Its Cash WiselySimply Wall St. · 04-26
The file stays open
69 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice